Sept 28 (Reuters) – Merck & Co Inc: * SAYS MERCK ENTERS EXCLUSIVE GLOBAL LICENSE DEAL WITH SCIBRUNCH THERAPEUTICS FOR INVESTIGATIONAL ORAL KRAS G12D (ON) INHIBITOR SPR2015 Source text Further company
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Sept 28 (Reuters) - TCL Zhonghuan Renewable Energy Technology Co Ltd: * PLANS A-SHARE BUYBACK…
VIDEO SHOWS: BELGIUM AND FRANCE FOOTBALL TEAMS TRAINING AHEAD OF UEFA NATIONS MATCH/ SOUNDBITES FROM…
By Johann M Cherian and Tharuniyaa Lakshmi Sept 28 (Reuters) - US stock index futures…
LONDON, Sept 28 (Reuters) - Britain's Competition Appeal Tribunal on Monday allowed part of a…
Sept 28 (Reuters) - Coats Group PLC: * COATS GROUP PLC - BOARD CHANGES AND…
VIDEO SHOWS: HIGHLIGHTS OF THE MEN'S ELITE ROAD RACE AT THE UCI WORLD ROAD CHAMPIONSHIPS…